Yurugi H - Search Results

1

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L. Chouha N, et al. Among authors: yurugi h. Eur J Med Chem. 2022 Nov 15;242:114635. doi: 10.1016/j.ejmech.2022.114635. Epub 2022 Aug 4. Eur J Med Chem. 2022. PMID: 35988448 Free article.

2

A role for prohibitin in mast cell activation: location matters.

Yurugi H, Rajalingam K. Yurugi H, et al. Sci Signal. 2013 Sep 10;6(292):pe29. doi: 10.1126/scisignal.2004646. Sci Signal. 2013. PMID: 24023253

3

Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours.

Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, Désaubry L, Rajalingam K. Yurugi H, et al. Oncogene. 2017 Aug 17;36(33):4778-4789. doi: 10.1038/onc.2017.93. Epub 2017 Apr 17. Oncogene. 2017. PMID: 28414306

4

Ubiquitin-dependent regulation of Cdc42 by XIAP.

Murali A, Shin J, Yurugi H, Krishnan A, Akutsu M, Carpy A, Macek B, Rajalingam K. Murali A, et al. Among authors: yurugi h. Cell Death Dis. 2017 Jun 29;8(6):e2900. doi: 10.1038/cddis.2017.305. Cell Death Dis. 2017. PMID: 28661476 Free PMC article.

5

Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity.

Buehler U, Schulenburg K, Yurugi H, Šolman M, Abankwa D, Ulges A, Tenzer S, Bopp T, Thiede B, Zipp F, Rajalingam K. Buehler U, et al. Among authors: yurugi h. EMBO J. 2018 Aug 15;37(16):e99429. doi: 10.15252/embj.201899429. Epub 2018 Jul 26. EMBO J. 2018. PMID: 30049713 Free PMC article.

6

Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Wang D, Tabti R, Elderwish S, Abou-Hamdan H, Djehal A, Yu P, Yurugi H, Rajalingam K, Nebigil CG, Désaubry L. Wang D, et al. Among authors: yurugi h. Cell Mol Life Sci. 2020 Sep;77(18):3525-3546. doi: 10.1007/s00018-020-03475-1. Epub 2020 Feb 15. Cell Mol Life Sci. 2020. PMID: 32062751 Free PMC article. Review.

7

A subset of flavaglines inhibits KRAS nanoclustering and activation.

Yurugi H, Zhuang Y, Siddiqui FA, Liang H, Rosigkeit S, Zeng Y, Abou-Hamdan H, Bockamp E, Zhou Y, Abankwa D, Zhao W, Désaubry L, Rajalingam K. Yurugi H, et al. J Cell Sci. 2020 Jun 24;133(12):jcs244111. doi: 10.1242/jcs.244111. J Cell Sci. 2020. PMID: 32501281

8

[No title available]

[No authors listed] [No authors listed] PMID: 34005204

9

ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression.

Riegel K, Yurugi H, Schlöder J, Jonuleit H, Kaulich M, Kirschner F, Arnold-Schild D, Tenzer S, Schild H, Rajalingam K. Riegel K, et al. Among authors: yurugi h. Cell Death Dis. 2021 Oct 20;12(11):969. doi: 10.1038/s41419-021-04257-8. Cell Death Dis. 2021. PMID: 34671021 Free PMC article.

10

Proteome landscape and interactome of voltage-gated potassium channel 1.6 (Kv1.6) of the murine ophthalmic artery and neuroretina.

Perumal N, Yurugi H, Dahm K, Rajalingam K, Grus FH, Pfeiffer N, Manicam C. Perumal N, et al. Among authors: yurugi h. Int J Biol Macromol. 2024 Feb;257(Pt 1):128464. doi: 10.1016/j.ijbiomac.2023.128464. Epub 2023 Dec 2. Int J Biol Macromol. 2024. PMID: 38043654 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page